Your browser doesn't support javascript.
loading
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer.
Rammensee, Hans-Georg; Wiesmüller, Karl-Heinz; Chandran, P Anoop; Zelba, Henning; Rusch, Elisa; Gouttefangeas, Cécile; Kowalewski, Daniel J; Di Marco, Moreno; Haen, Sebastian P; Walz, Juliane S; Gloria, Yamel Cardona; Bödder, Johanna; Schertel, Jill-Marie; Tunger, Antje; Müller, Luise; Kießler, Maximilian; Wehner, Rebekka; Schmitz, Marc; Jakobi, Meike; Schneiderhan-Marra, Nicole; Klein, Reinhild; Laske, Karoline; Artzner, Kerstin; Backert, Linus; Schuster, Heiko; Schwenck, Johannes; Weber, Alexander N R; Pichler, Bernd J; Kneilling, Manfred; la Fougère, Christian; Forchhammer, Stephan; Metzler, Gisela; Bauer, Jürgen; Weide, Benjamin; Schippert, Wilfried; Stevanovic, Stefan; Löffler, Markus W.
Afiliação
  • Rammensee HG; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany. rammensee@uni-tuebingen.de.
  • Wiesmüller KH; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany. rammensee@uni-tuebingen.de.
  • Chandran PA; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tubingen, Germany. rammensee@uni-tuebingen.de.
  • Zelba H; EMC microcollections GmbH, Tübingen, Germany.
  • Rusch E; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
  • Gouttefangeas C; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
  • Kowalewski DJ; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
  • Di Marco M; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
  • Haen SP; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.
  • Walz JS; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tubingen, Germany.
  • Gloria YC; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
  • Bödder J; Present address: Immatics Biotechnologies GmbH, Tübingen, Germany.
  • Schertel JM; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
  • Tunger A; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
  • Müller L; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.
  • Kießler M; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany.
  • Wehner R; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
  • Schmitz M; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.
  • Jakobi M; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tubingen, Germany.
  • Schneiderhan-Marra N; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany.
  • Klein R; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
  • Laske K; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
  • Artzner K; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.
  • Backert L; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.
  • Schuster H; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Ros
  • Schwenck J; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.
  • Weber ANR; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.
  • Pichler BJ; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.
  • Kneilling M; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Ros
  • la Fougère C; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Forchhammer S; Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany.
  • Metzler G; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/ Helmholtz-Zentrum Dresden-Ros
  • Bauer J; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weide B; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
  • Schippert W; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
  • Stevanovic S; Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tübingen, Tübingen, Germany.
  • Löffler MW; Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.
J Immunother Cancer ; 7(1): 307, 2019 11 15.
Article em En | MEDLINE | ID: mdl-31730025
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article